Diogo Haddad Santos

Amyloid-beta-targeting monoclonal antibodies in early Alzheimer’s disease: a cochrane review summary and appraisal for the neurological community

Abstract Background Seven amyloid-beta-targeting monoclonal antibodies have been trialled in early Alzheimer’s disease. They differ in epitope and in how much plaque they clear; only two have traditional approval. A 2026 Cochrane Review pooled all seven as one class. We ask what...